ABVC Biopharma Inc
NASDAQ:ABVC

Watchlist Manager
ABVC Biopharma Inc Logo
ABVC Biopharma Inc
NASDAQ:ABVC
Watchlist
Price: 0.935 USD -9.09% Market Closed
Updated: May 25, 2024

ABVC Biopharma Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABVC Biopharma Inc
Pre-Tax Income Peer Comparison

Comparables:
AMGN
ALNY
INCY
KRTX
MRNA

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
ABVC Biopharma Inc
NASDAQ:ABVC
Pre-Tax Income
-$10.7m
CAGR 3-Years
0%
CAGR 5-Years
-11%
CAGR 10-Years
-63%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$4.3B
CAGR 3-Years
-18%
CAGR 5-Years
-14%
CAGR 10-Years
-2%
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Pre-Tax Income
-$324.8m
CAGR 3-Years
28%
CAGR 5-Years
17%
CAGR 10-Years
1%
Incyte Corp
NASDAQ:INCY
Pre-Tax Income
$1B
CAGR 3-Years
23%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Karuna Therapeutics Inc
NASDAQ:KRTX
Pre-Tax Income
-$433m
CAGR 3-Years
-85%
CAGR 5-Years
-90%
CAGR 10-Years
N/A
Moderna Inc
NASDAQ:MRNA
Pre-Tax Income
-$4.8B
CAGR 3-Years
N/A
CAGR 5-Years
-61%
CAGR 10-Years
N/A

See Also

What is ABVC Biopharma Inc's Pre-Tax Income?
Pre-Tax Income
-10.7m USD

Based on the financial report for Dec 31, 2023, ABVC Biopharma Inc's Pre-Tax Income amounts to -10.7m USD.

What is ABVC Biopharma Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-63%

Over the last year, the Pre-Tax Income growth was 31%.